September 23, 2021
Gibson, Dunn & Crutcher LLP is pleased to announce that Brendan Stewart has joined the firm as an of counsel in its New York office. He will serve as a member of the White Collar Defense and Investigations, FDA and Health Care, False Claims Act/Qui Tam Defense, and Litigation Practice Groups. Stewart’s practice will focus on health care enforcement, compliance, and litigation as well as other white collar enforcement matters and related litigation.
Prior to joining Gibson Dunn, Stewart served as an Assistant Chief in the Fraud Section of the U.S. Department of Justice’s Criminal Division, where he oversaw a unit of health care fraud prosecutors in the Eastern District of New York from 2017 to 2021. As a senior prosecutor and supervisor, his responsibilities at DOJ covered a wide range of areas central to the health care and life sciences industries, including health care providers and companies in the pharmaceutical, medical device, genetic and diagnostic testing, biotechnology, and telemedicine fields. Stewart led numerous complex investigations in coordination with the U.S. Attorney’s Office, the Federal Bureau of Investigation, the Department of Health and Human Services’ Office of Inspector General, State Attorneys General, and other federal and local law enforcement agencies. A federal prosecutor since 2012, Stewart has tried complex fraud cases before juries across the country, including in New York, California, Michigan, and Florida. Prior to government service, he began his legal career as an associate at a major international law firm.
“We’re excited to welcome Brendan to the Gibson Dunn team. His experience as a federal prosecutor leading major health care and False Claims Act investigations and trials in New York and around the country will be a strong addition to our preeminent White Collar practice,” said Joel M. Cohen, Co-Chair of the firm’s White Collar Defense and Investigations Practice Group.
Stewart received his law degree from Columbia Law School in 2003, where he was Editor of the Columbia Law Review and a Harlan Fiske Stone Scholar.